SABS

SAB Biotherapeutics, Inc.

Insider trading activity for SAB Biotherapeutics, Inc., straight from SEC Form 4 filings. Net figures below count open-market buys and sales only — grants, option exercises and tax withholding are excluded because they are compensation, not decisions to trade.

Past 3 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Past 6 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Past 12 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Transaction history

The 33 most recent Form 4 transactions.

Open in screener →

Insider transactions, newest first: date, security, transaction type, size and a link to the filing each row came from.
Date	Insider	Role	Type	Shares	Price	Value	Δ Own	Filing
Sep 17	Kropotova Alexandra	Chief Medical Officer	FTAX	473	—	—	-1.1%	Open the original filing on SEC.gov
Jun 25	Kropotova Alexandra	Chief Medical Officer	FTAX	988	—	—	-2.3%	Open the original filing on SEC.gov
Mar 24	Kropotova Alexandra	Chief Medical Officer	FTAX	988	—	—	-2.2%	Open the original filing on SEC.gov
Feb 3	Sullivan Eddie Joe	President	AGRANT◆	3M	—	—	—	Open the original filing on SEC.gov
Feb 3	To Lucy	See Remarks	AGRANT◆	2.4M	—	—	—	Open the original filing on SEC.gov
Feb 3	Reich Samuel J	CEO	AGRANT◆	4.8M	—	—	—	Open the original filing on SEC.gov
Feb 3	Kropotova Alexandra	Chief Medical Officer	AGRANT◆	2.4M	—	—	—	Open the original filing on SEC.gov
Feb 3	Bausch Christoph…	Chief Operating Officer	AGRANT◆	1.8M	—	—	—	Open the original filing on SEC.gov
Jan 5	Zaccardelli David	Director	AGRANT◆	240,000	—	—	—	Open the original filing on SEC.gov
Jan 5	Jain Rita	Director	AGRANT◆	240,000	—	—	—	Open the original filing on SEC.gov
Dec 16, 2025	Skyler Jay S	Director	AGRANT◆	150,000	—	—	—	Open the original filing on SEC.gov
Dec 16, 2025	Polvino William James	Director	AGRANT◆	150,000	—	—	—	Open the original filing on SEC.gov
Dec 16, 2025	Lucera Erick	Director	AGRANT◆	150,000	—	—	—	Open the original filing on SEC.gov
Dec 16, 2025	Link David	Director	AGRANT◆	150,000	—	—	—	Open the original filing on SEC.gov
Dec 16, 2025	Giberson Scott	Director	AGRANT◆	150,000	—	—	—	Open the original filing on SEC.gov
Dec 16, 2025	Ellias Helen K.	Director	AGRANT◆	150,000	—	—	—	Open the original filing on SEC.gov
Dec 11, 2025	Kropotova Alexandra	Chief Medical Officer	FTAX	988	—	—	-2.2%	Open the original filing on SEC.gov
Sep 29, 2025	Sessa Capital (Master),…	Director	MEXER◆	17,400	—	—	—	Open the original filing on SEC.gov
Sep 29, 2025	Sessa Capital (Master),…	Director	MEXER	1.7M	$1.75	$3M	+379.5%	Open the original filing on SEC.gov
Sep 29, 2025	Moin Andrew	Director	MEXER◆	17,400	—	—	—	Open the original filing on SEC.gov
Sep 29, 2025	Moin Andrew	Director	MEXER	1.7M	$1.75	$3M	+379.5%	Open the original filing on SEC.gov
Sep 19, 2025	Kropotova Alexandra	Chief Medical Officer	FTAX	1,977	—	—	-4.2%	Open the original filing on SEC.gov
Aug 26, 2025	To Lucy	See Remarks	AGRANT◆	1.2M	—	—	—	Open the original filing on SEC.gov
Aug 26, 2025	Sullivan Eddie Joe	President	AGRANT◆	3M	—	—	—	Open the original filing on SEC.gov
Aug 26, 2025	Reich Samuel J	CEO & Executive Chairman	AGRANT◆	4.8M	—	—	—	Open the original filing on SEC.gov
Aug 26, 2025	Kropotova Alexandra	Chief Medical Officer	AGRANT◆	2.4M	—	—	—	Open the original filing on SEC.gov
Aug 26, 2025	Bausch Christoph…	Chief Operating Officer	AGRANT◆	600,000	—	—	—	Open the original filing on SEC.gov
Jul 22, 2025	Sessa Capital (Master),…	Director	AGRANT◆	114,250	—	—	—	Open the original filing on SEC.gov
Jul 22, 2025	Sessa Capital (Master),…	Director	AGRANT◆	228,500	—	—	—	Open the original filing on SEC.gov
Jul 22, 2025	Sessa Capital (Master),…	Director	AGRANT◆	228,500	—	—	—	Open the original filing on SEC.gov
Jul 22, 2025	Moin Andrew	Director	AGRANT◆	114,250	—	—	—	Open the original filing on SEC.gov
Jul 22, 2025	Moin Andrew	Director	AGRANT◆	228,500	—	—	—	Open the original filing on SEC.gov
Jul 22, 2025	Moin Andrew	Director	AGRANT◆	228,500	—	—	—	Open the original filing on SEC.gov

FTAX—

Kropotova Alexandra · Chief Medical…Sep 17

473 sh · -1.1% own

FTAX—

Kropotova Alexandra · Chief Medical…Jun 25

988 sh · -2.3% own

FTAX—

Kropotova Alexandra · Chief Medical…Mar 24

988 sh · -2.2% own

AGRANT◆—

Sullivan Eddie Joe · PresidentFeb 3

3M sh

AGRANT◆—

To Lucy · See RemarksFeb 3

2.4M sh

AGRANT◆—

Reich Samuel J · CEOFeb 3

4.8M sh

AGRANT◆—

Kropotova Alexandra · Chief Medical…Feb 3

2.4M sh

AGRANT◆—

Bausch Christoph… · Chief Operating…Feb 3

1.8M sh

AGRANT◆—

Zaccardelli David · DirectorJan 5

240,000 sh

AGRANT◆—

Jain Rita · DirectorJan 5

240,000 sh

AGRANT◆—

Skyler Jay S · DirectorDec 16, 2025

150,000 sh

AGRANT◆—

Polvino William James · DirectorDec 16, 2025

150,000 sh

AGRANT◆—

Lucera Erick · DirectorDec 16, 2025

150,000 sh

AGRANT◆—

Link David · DirectorDec 16, 2025

150,000 sh

AGRANT◆—

Giberson Scott · DirectorDec 16, 2025

150,000 sh

AGRANT◆—

Ellias Helen K. · DirectorDec 16, 2025

150,000 sh

FTAX—

Kropotova Alexandra · Chief Medical…Dec 11, 2025

988 sh · -2.2% own

MEXER◆—

Sessa Capital (Master),… · DirectorSep 29, 2025

17,400 sh

MEXER$3M

Sessa Capital (Master),… · DirectorSep 29, 2025

1.7M sh @ $1.75 · +379.5% own

MEXER◆—

Moin Andrew · DirectorSep 29, 2025

17,400 sh

MEXER$3M

Moin Andrew · DirectorSep 29, 2025

1.7M sh @ $1.75 · +379.5% own

FTAX—

Kropotova Alexandra · Chief Medical…Sep 19, 2025

1,977 sh · -4.2% own

AGRANT◆—

To Lucy · See RemarksAug 26, 2025

1.2M sh

AGRANT◆—

Sullivan Eddie Joe · PresidentAug 26, 2025

3M sh

AGRANT◆—

Reich Samuel J · CEO & Executive…Aug 26, 2025

4.8M sh

AGRANT◆—

Kropotova Alexandra · Chief Medical…Aug 26, 2025

2.4M sh

AGRANT◆—

Bausch Christoph… · Chief Operating…Aug 26, 2025

600,000 sh

AGRANT◆—

Sessa Capital (Master),… · DirectorJul 22, 2025

114,250 sh

AGRANT◆—

Sessa Capital (Master),… · DirectorJul 22, 2025

228,500 sh

AGRANT◆—

Sessa Capital (Master),… · DirectorJul 22, 2025

228,500 sh

AGRANT◆—

Moin Andrew · DirectorJul 22, 2025

114,250 sh

AGRANT◆—

Moin Andrew · DirectorJul 22, 2025

228,500 sh

AGRANT◆—

Moin Andrew · DirectorJul 22, 2025

228,500 sh

Filing record

How quickly insiders here report their trades. Section 16 allows two business days from the transaction.

All 27 filings we hold were filed within the two-business-day deadline.

Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings

Insiders at this company

Everyone who has filed a Form 4 for this issuer.

More biotech & pharma companies

Other issuers in the same industry with insider filings on record.

Whole sector →